AKEBIA THERAPEUTICS, INC. (AKBA) ROI
- 2026-06-30: ROI -39.78%.
- 2026-03-31: ROI -26.89%.
- 2025-12-31: ROI -6.61%.
- 2024-12-31: ROI 661.55%.
Complete source-backed roi history.
- Available history
- 2020-12-31 to 2026-06-30
- Data captured
Historical ROI
| Date | ROI |
|---|---|
| 2026-06-30 | -39.78% |
| 2026-03-31 | -26.89% |
| 2025-12-31 | -6.61% |
| 2024-12-31 | 661.55% |
| 2024-09-30 | 381.77% |
| 2024-06-30 | -945.57% |
| 2024-03-31 | -1490.54% |
| 2023-12-31 | -1266.72% |
| 2023-09-30 | -1835.52% |
| 2023-06-30 | -626.33% |
| 2023-03-31 | -184.76% |
| 2022-12-31 | -132.14% |
| 2022-09-30 | -113.33% |
| 2022-06-30 | -64.36% |
| 2021-12-31 | -164.87% |
| 2020-12-31 | -111.47% |
Annual ROI
| Date | ROI |
|---|---|
| 2024-12-31 | 661.55% |
| 2023-12-31 | -1266.77% |
| 2022-12-31 | -132.14% |
| 2021-12-31 | -164.87% |
| 2020-12-31 | -111.47% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |